2145 Masitinib plus FOLFIRI for second-line treatment of metastatic colorectal cancer: 2-year follow-up of phase open label trialJulien Taieb,Christophe Borg,Thierry Lecomte,Céline Lepère, T. Chatellier,Denis Smith,P Dubreuil,C. Mansfield,Alain Moussy,Olivier HermineEUROPEAN JOURNAL OF CANCER(2015)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要